FR3000399B1 - Utilisation topique du laropiprant pour le traitement de la rosacee - Google Patents

Utilisation topique du laropiprant pour le traitement de la rosacee

Info

Publication number
FR3000399B1
FR3000399B1 FR1262973A FR1262973A FR3000399B1 FR 3000399 B1 FR3000399 B1 FR 3000399B1 FR 1262973 A FR1262973 A FR 1262973A FR 1262973 A FR1262973 A FR 1262973A FR 3000399 B1 FR3000399 B1 FR 3000399B1
Authority
FR
France
Prior art keywords
laropiprant
rosacea
treatment
topical use
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1262973A
Other languages
English (en)
Other versions
FR3000399A1 (fr
Inventor
Carine Rosignoli
Jerome Aubert
Jean Francois Fournier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to FR1262973A priority Critical patent/FR3000399B1/fr
Priority to PCT/FR2013/052324 priority patent/WO2014049300A1/fr
Publication of FR3000399A1 publication Critical patent/FR3000399A1/fr
Application granted granted Critical
Publication of FR3000399B1 publication Critical patent/FR3000399B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1262973A 2012-09-28 2012-12-31 Utilisation topique du laropiprant pour le traitement de la rosacee Expired - Fee Related FR3000399B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1262973A FR3000399B1 (fr) 2012-12-31 2012-12-31 Utilisation topique du laropiprant pour le traitement de la rosacee
PCT/FR2013/052324 WO2014049300A1 (fr) 2012-09-28 2013-09-30 Utilisation topique du laropiprant pour le traitement de la rosacée

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1262973A FR3000399B1 (fr) 2012-12-31 2012-12-31 Utilisation topique du laropiprant pour le traitement de la rosacee

Publications (2)

Publication Number Publication Date
FR3000399A1 FR3000399A1 (fr) 2014-07-04
FR3000399B1 true FR3000399B1 (fr) 2015-03-27

Family

ID=47989208

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1262973A Expired - Fee Related FR3000399B1 (fr) 2012-09-28 2012-12-31 Utilisation topique du laropiprant pour le traitement de la rosacee

Country Status (2)

Country Link
FR (1) FR3000399B1 (fr)
WO (1) WO2014049300A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016346203B2 (en) 2015-10-30 2021-05-27 Leo Pharma A/S Isotretinoin formulations and uses and methods thereof
FR3088543B1 (fr) 2018-11-21 2021-03-19 Waterdiam France Traitement des affections de la peau à base d’eau électrolysée

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952372A (en) 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
AR038136A1 (es) * 2002-01-24 2004-12-29 Merck Frosst Canada Inc Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
US20070299122A1 (en) * 2004-11-08 2007-12-27 Tobert Jonathan A Method of Treating Pathological Blushing
PL2037967T3 (pl) * 2006-06-16 2017-07-31 The Trustees Of The University Of Pennsylvania Antagoniści receptora prostaglandyny D2 w leczeniu łysienia androgenowego
WO2011014588A2 (fr) * 2009-07-31 2011-02-03 Amira Pharmaceuticals, Inc. Préparations dermiques d'antagonistes du récepteur dp2

Also Published As

Publication number Publication date
WO2014049300A1 (fr) 2014-04-03
FR3000399A1 (fr) 2014-07-04

Similar Documents

Publication Publication Date Title
HK1226161A1 (zh) 動態確定臨床狀況的風險
DK2879636T3 (da) Sårbandage
DK2872485T3 (da) Asymmetrisk hjælpegruppe
BR112014028633A2 (pt) tratamento de amd usando sflt-1 de aav
DK3382201T3 (da) Flydende legeme-struktur
BR112015002877A2 (pt) dispositivo de curativo integrado
BR112014031335A2 (pt) bloco de diagnóstico transacional
DK2827813T3 (da) Kuldebehandlingsindretning
DK2764881T3 (da) System til medicinsk behandling
DK3013317T3 (da) Silicahydrogelkomposit
FR3015698B1 (fr) Endoscope et procede pour son utilisation
BR112014019587A2 (pt) Sistema de curativo
DK3563837T5 (da) Bakteriofagterapi
FR20C1044I2 (fr) Triazines pour le traitement des infections protozoïques
FR2993464B1 (fr) Pansement interface autoporte
FR3000491B1 (fr) Composes utilisables dans le traitement des infections mycobacteriennes
FR3015285B1 (fr) Formulation pour le traitement des cheveux
BR112015032639A2 (pt) Guindaste
DK2976101T3 (da) Behandlingsfremgangsmåde
DK2948116T3 (da) Sårforbinding
DK2819711T3 (da) Antiseptisk sårforbinding
DK2647359T3 (da) Kompressionsforbinding
FR3000399B1 (fr) Utilisation topique du laropiprant pour le traitement de la rosacee
EP2947462A4 (fr) Système de traitement d'échantillon
ITRM20120473A1 (it) Use of glycerophosphoinositols for the treatment of septic shock

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160831